Ad is loading...
CELC
Price
$12.78
Change
-$0.00 (-0.00%)
Updated
Nov 20 closing price
118 days until earnings call
INZY
Price
$2.69
Change
-$0.10 (-3.58%)
Updated
Nov 21 closing price
118 days until earnings call
Ad is loading...

CELC vs INZY

Header iconCELC vs INZY Comparison
Open Charts CELC vs INZYBanner chart's image
Celcuity
Price$12.78
Change-$0.00 (-0.00%)
Volume$261.76K
CapitalizationN/A
Inozyme Pharma
Price$2.69
Change-$0.10 (-3.58%)
Volume$371.49K
CapitalizationN/A
CELC vs INZY Comparison Chart
Loading...
CELC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
View a ticker or compare two or three
VS
CELC vs. INZY commentary
Nov 22, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CELC is a StrongSell and INZY is a Buy.

COMPARISON
Comparison
Nov 22, 2024
Stock price -- (CELC: $12.73 vs. INZY: $2.69)
Brand notoriety: CELC and INZY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CELC: 78% vs. INZY: 138%
Market capitalization -- CELC: $472.66M vs. INZY: $179.23M
CELC [@Biotechnology] is valued at $472.66M. INZY’s [@Biotechnology] market capitalization is $179.23M. The market cap for tickers in the [@Biotechnology] industry ranges from $463.61B to $0. The average market capitalization across the [@Biotechnology] industry is $2.63B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CELC’s FA Score shows that 0 FA rating(s) are green whileINZY’s FA Score has 1 green FA rating(s).

  • CELC’s FA Score: 0 green, 5 red.
  • INZY’s FA Score: 1 green, 4 red.
According to our system of comparison, both CELC and INZY are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CELC’s TA Score shows that 5 TA indicator(s) are bullish while INZY’s TA Score has 4 bullish TA indicator(s).

  • CELC’s TA Score: 5 bullish, 5 bearish.
  • INZY’s TA Score: 4 bullish, 7 bearish.
According to our system of comparison, CELC is a better buy in the short-term than INZY.

Price Growth

CELC (@Biotechnology) experienced а -9.78% price change this week, while INZY (@Biotechnology) price change was -21.57% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -3.74%. For the same industry, the average monthly price growth was -7.78%, and the average quarterly price growth was +1.53%.

Reported Earning Dates

CELC is expected to report earnings on Mar 20, 2025.

INZY is expected to report earnings on Mar 20, 2025.

Industries' Descriptions

@Biotechnology (-3.74% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CELC($473M) has a higher market cap than INZY($179M). CELC YTD gains are higher at: -12.629 vs. INZY (-36.854). CELC has higher annual earnings (EBITDA): -85.45M vs. INZY (-90.3M). CELC has more cash in the bank: 264M vs. INZY (132M). INZY has less debt than CELC: INZY (46.8M) vs CELC (97.2M). CELC (0) and INZY (0) have equivalent revenues.
CELCINZYCELC / INZY
Capitalization473M179M264%
EBITDA-85.45M-90.3M95%
Gain YTD-12.629-36.85434%
P/E RatioN/AN/A-
Revenue00-
Total Cash264M132M200%
Total Debt97.2M46.8M208%
FUNDAMENTALS RATINGS
CELC: Fundamental Ratings
CELC
OUTLOOK RATING
1..100
61
VALUATION
overvalued / fair valued / undervalued
1..100
40
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
83
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CELCINZY
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
83%
Stochastic
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
89%
Momentum
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
90%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
89%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
85%
Bearish Trend 1 day ago
90%
Advances
ODDS (%)
Bullish Trend 3 days ago
84%
Bullish Trend 19 days ago
86%
Declines
ODDS (%)
Bearish Trend 5 days ago
88%
Bearish Trend 1 day ago
90%
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
90%
Aroon
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
90%
View a ticker or compare two or three
Ad is loading...
CELC
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
INZY
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
ZDIVX27.720.31
+1.13%
Zacks Dividend Investor
CAFRX8.800.06
+0.69%
Commonwealth Africa
FDTTX25.340.17
+0.68%
Fidelity Advisor Capital Development A
TFFIX76.000.19
+0.25%
Touchstone Focused Instl
PIGRX14.020.01
+0.07%
Putnam International Value C

CELC and

Correlation & Price change

A.I.dvisor indicates that over the last year, CELC has been loosely correlated with PLRX. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if CELC jumps, then PLRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CELC
1D Price
Change %
CELC100%
-0.39%
PLRX - CELC
42%
Loosely correlated
+0.94%
INZY - CELC
41%
Loosely correlated
-3.58%
SNDX - CELC
40%
Loosely correlated
-2.19%
ABOS - CELC
39%
Loosely correlated
-2.53%
AVTX - CELC
39%
Loosely correlated
-11.47%
More

INZY and

Correlation & Price change

A.I.dvisor indicates that over the last year, INZY has been loosely correlated with BEAM. These tickers have moved in lockstep 56% of the time. This A.I.-generated data suggests there is some statistical probability that if INZY jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To INZY
1D Price
Change %
INZY100%
-3.58%
BEAM - INZY
56%
Loosely correlated
-3.72%
FATE - INZY
49%
Loosely correlated
-6.76%
ABOS - INZY
49%
Loosely correlated
-2.53%
DNLI - INZY
49%
Loosely correlated
-0.82%
PGEN - INZY
48%
Loosely correlated
+7.91%
More